-
Cleveland Clinic raises $29M for cancer research
Cleveland Clinic's VeloSano Cancer Research Accelerator Fund raised $29 million in 2024, the most raised annually since the fund's inception. -
UVA Cancer Center launches rural lung cancer screening initiative
Charlottesville, Va.-based UVA Cancer Center has partnered with the Appalachian Community Cancer Alliance and Grundy, Va.-based Buchanan General Hospital to bring lung cancer screening to rural Virginia and West Virginia residents. -
Lung cancer diagnoses rising among young, middle-age women
Although lung cancer incidence rates are declining, more young and middle-age women are being diagnosed at higher rates than men, CNN reported Nov. 25. -
Latest FDA oncology drug approvals
There have been 11 cancer-related novel drug approvals in 2024, according to the FDA website. -
Tackling cancer care equity with tech: 5 things to know
The President's Cancer Panel, an independent group tasked with monitoring the National Cancer Plan, has released a new report highlighting ways to achieve cancer care equity through technology. -
Healthy women have cells that mimic appearance of breast cancer: 5 notes
At least 3% of breast tissue cells from healthy women contain chromosome abnormalities that are typically associated with breast cancer, according to a study published Nov. 20 in Nature. -
Comprehensive cancer centers report 23% lower mortality rate
Cancer patient overall mortality risk is 23% lower if they are receiving care at an National Cancer Institute-designated comprehensive cancer center compared to cancer centers without the designation, according to a study published Nov. 20 in the American Cancer Society's interdisciplinary journal, Cancer. -
US Oncology Network launches nurse retention program
The US Oncology Network launched a professional development and retention program for new oncology nurses. -
8 systems seeking oncology leaders
Here are eight health systems seeking oncology leaders: -
2024 'State of Lung Cancer' report: 7 takeaways
The American Lung Association released its 2024 "State of Lung Cancer" report, highlighting a 26% increase in survival and a 15% decrease in incidence, though care disparities across state lines and demographics are still influencing patient outcomes. -
Fox Chase Cancer Center wins international care team award
A lung cancer care team at Fox Chase Cancer Center and Temple University Health System, both based in Philadelphia, has received the North American Cancer Care Team Award from the International Association for the Study of Lung Cancer. -
Melanoma rates steadily decline among younger generations
Melanoma rates have been steadily declining among younger generations over the past two decades, according to a study published Nov. 15 in the Journal of the American Academy of Dermatology. -
Baptist Health to open new cancer center in Key West
Baptist Health plans to expand its cancer care services with the opening of a standalone cancer center in Key West, Fla. -
How MD Anderson uses teleconsulting to tackle care gaps
Cancer centers across the U.S. are continually developing innovative solutions to address growing cancer care gaps. These solutions often include increasing access to valuable cancer trials or highly targeted screening initiatives. -
Rise in pancreatic cancer tied to better detection, study suggests
The rise in pancreatic cancer diagnoses can be attributed to previously undetected disease and not a rise in cancer occurrence, according to a study published Nov. 19 in the Annals of Internal Medicine. -
UC Davis cancer center taps physician-in-chief
Sacramento, Calif.-based UC Davis Health has permanently named David Cooke, MD, as physician-in-chief for the UC Davis Comprehensive Cancer Center. -
Adolescent, young adult global cancer burden to increase 12% by 2050: 6 notes
The global cancer burden of adolescents and young adults is projected to increase by approximately 12% by 2050, according to a Nov. 15 study published in The Lancet Oncology. -
Penn Medicine names new cancer institute leader
Penn Medicine Lancaster (Pa.) General Health has named Efrat Dotan, MD, as executive medical director of the Ann B. Barshinger Cancer Institute. -
Skin cancer diagnosis accuracy varies by physician: 4 study notes
Compared to primary care physicians, dermatologists have 13.3-fold higher accuracy when diagnosing melanoma using dermoscopic images, according to a study published Nov. 13 in JAMA Dermatology. -
Providence Cancer Institute in Oregon taps new leader
Bryan Bell, MD, DDS, has accepted the roles of executive medical director of Providence Cancer Institute and director of its research arm, the Earle A. Chiles Research Institute, both based in Portland, Ore., according to a news release shared with Becker's.
Page 2 of 50